| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-168. e14, 2020 | 1925 | 2020 |
| Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial P Bergman, O Blennow, L Hansson, S Mielke, P Nowak, P Chen, ... EBioMedicine 74, 2021 | 205 | 2021 |
| Cytotoxic T-cells mediate exercise-induced reductions in tumor growth H Rundqvist, P Veliça, L Barbieri, PA Gameiro, D Bargiela, M Gojkovic, ... Elife 9, e59996, 2020 | 136 | 2020 |
| Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination Y Gao, C Cai, D Wullimann, J Niessl, O Rivera-Ballesteros, P Chen, ... Immunity 55 (9), 1732-1746. e5, 2022 | 51 | 2022 |
| Cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-68, 2020 | 29 | 2020 |
| NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals A Cuapio, C Boulouis, I Filipovic, D Wullimann, T Kammann, T Parrot, ... Molecular Medicine 28 (1), 20, 2022 | 27 | 2022 |
| Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age M Humbert, A Olofsson, D Wullimann, J Niessl, EB Hodcroft, C Cai, Y Gao, ... Proceedings of the National Academy of Sciences 120 (12), e2220320120, 2023 | 19 | 2023 |
| MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine C Boulouis, T Kammann, A Cuapio, T Parrot, Y Gao, E Mouchtaridi, ... Molecular Medicine 28 (1), 54, 2022 | 19 | 2022 |
| Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common … P Bergman, D Wullimann, Y Gao, E Wahren Borgström, AC Norlin, ... Journal of Clinical Immunology 42 (4), 716-727, 2022 | 19 | 2022 |
| T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label … L Blixt, D Wullimann, S Aleman, J Lundin, P Chen, Y Gao, A Cuapio, ... Haematologica 107 (4), 1000, 2022 | 14 | 2022 |
| Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination L Blixt, Y Gao, D Wullimann, H Murén Ingelman-Sundberg, S Muschiol, ... Blood, The Journal of the American Society of Hematology 140 (22), 2403-2407, 2022 | 9 | 2022 |
| Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID P Chen, P Bergman, O Blennow, L Hansson, S Mielke, P Nowak, ... EBioMedicine 94, 2023 | 3 | 2023 |
| The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes HG Ljunggren, E Heggernes Ask, M Cornillet, B Strunz, P Chen, ... Scandinavian Journal of Immunology 96 (1), e13195, 2022 | 3 | 2022 |
| Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia HM Ingelman-Sundberg, L Blixt, D Wullimann, J Wu, Y Gao, K Healy, ... Haematologica 109 (2), 646, 2024 | 1 | 2024 |
| Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia M Andersson, J Wu, D Wullimann, Y Gao, M Aberg, S Muschiol, K Healy, ... Journal of Hematology 12 (4), 170, 2023 | 1 | 2023 |
| Discovery of candidate biomarkers for purification of atrial and ventricular cardiomyocytes derived from human pluripotent stemcells: Version 2 D Wullimann | | 2017 |
